434 related articles for article (PubMed ID: 30911134)
1. Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation.
Toffalori C; Zito L; Gambacorta V; Riba M; Oliveira G; Bucci G; Barcella M; Spinelli O; Greco R; Crucitti L; Cieri N; Noviello M; Manfredi F; Montaldo E; Ostuni R; Naldini MM; Gentner B; Waterhouse M; Zeiser R; Finke J; Hanoun M; Beelen DW; Gojo I; Luznik L; Onozawa M; Teshima T; Devillier R; Blaise D; Halkes CJM; Griffioen M; Carrabba MG; Bernardi M; Peccatori J; Barlassina C; Stupka E; Lazarevic D; Tonon G; Rambaldi A; Cittaro D; Bonini C; Fleischhauer K; Ciceri F; Vago L
Nat Med; 2019 Apr; 25(4):603-611. PubMed ID: 30911134
[TBL] [Abstract][Full Text] [Related]
2. Integrated Multiomic Profiling Identifies the Epigenetic Regulator PRC2 as a Therapeutic Target to Counteract Leukemia Immune Escape and Relapse.
Gambacorta V; Beretta S; Ciccimarra M; Zito L; Giannetti K; Andrisani A; Gnani D; Zanotti L; Oliveira G; Carrabba MG; Cittaro D; Merelli I; Ciceri F; Di Micco R; Vago L
Cancer Discov; 2022 Jun; 12(6):1449-1461. PubMed ID: 35255120
[TBL] [Abstract][Full Text] [Related]
3. Immune Escape of Relapsed AML Cells after Allogeneic Transplantation.
Christopher MJ; Petti AA; Rettig MP; Miller CA; Chendamarai E; Duncavage EJ; Klco JM; Helton NM; O'Laughlin M; Fronick CC; Fulton RS; Wilson RK; Wartman LD; Welch JS; Heath SE; Baty JD; Payton JE; Graubert TA; Link DC; Walter MJ; Westervelt P; Ley TJ; DiPersio JF
N Engl J Med; 2018 Dec; 379(24):2330-2341. PubMed ID: 30380364
[TBL] [Abstract][Full Text] [Related]
4. Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantation.
Stölzel F; Hackmann K; Kuithan F; Mohr B; Füssel M; Oelschlägel U; Thiede C; Röllig C; Platzbecker U; Schetelig J; Illmer T; Schaich M; Seliger B; Hartmann A; Baretton G; Zietz C; Ehninger G; Schrock E; Bornhäuser M
Transplantation; 2012 Apr; 93(7):744-9. PubMed ID: 22314337
[TBL] [Abstract][Full Text] [Related]
5. Immune profiling after allogeneic hematopoietic cell transplantation in pediatric acute myeloid leukemia.
Shahid S; Ceglia N; Le Luduec JB; McPherson A; Spitzer B; Kontopoulos T; Bojilova V; Panjwani MK; Roshal M; Shah SP; Abdel-Wahab O; Greenbaum B; Hsu KC
Blood Adv; 2023 Sep; 7(17):5069-5081. PubMed ID: 37327118
[TBL] [Abstract][Full Text] [Related]
6. The MHC-II antigen presentation machinery and B7 checkpoint ligands display distinctive patterns correlated with acute myeloid leukaemias blast cells HLA-DR expression.
Antohe I; Tanasa MP; Dăscălescu A; Dănăilă C; Titieanu A; Zlei M; Ivanov I; Sireteanu A; Cianga P
Immunobiology; 2021 Jan; 226(1):152049. PubMed ID: 33352400
[TBL] [Abstract][Full Text] [Related]
7. HLA-DPB1 mismatch alleles represent powerful leukemia rejection antigens in CD4 T-cell immunotherapy after allogeneic stem-cell transplantation.
Herr W; Eichinger Y; Beshay J; Bloetz A; Vatter S; Mirbeth C; Distler E; Hartwig UF; Thomas S
Leukemia; 2017 Feb; 31(2):434-445. PubMed ID: 27479183
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of Leukemia Immune Evasion and Their Role in Relapse After Haploidentical Hematopoietic Cell Transplantation.
Rovatti PE; Gambacorta V; Lorentino F; Ciceri F; Vago L
Front Immunol; 2020; 11():147. PubMed ID: 32158444
[TBL] [Abstract][Full Text] [Related]
10. CD80-Transfected acute myeloid leukemia cells induce primary allogeneic T-cell responses directed at patient specific minor histocompatibility antigens and leukemia-associated antigens.
Mutis T; Schrama E; Melief CJ; Goulmy E
Blood; 1998 Sep; 92(5):1677-84. PubMed ID: 9716596
[TBL] [Abstract][Full Text] [Related]
11. KIR3DL1/HLA-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell Transplantation.
Boudreau JE; Giglio F; Gooley TA; Stevenson PA; Le Luduec JB; Shaffer BC; Rajalingam R; Hou L; Hurley CK; Noreen H; Reed EF; Yu N; Vierra-Green C; Haagenson M; Malkki M; Petersdorf EW; Spellman S; Hsu KC
J Clin Oncol; 2017 Jul; 35(20):2268-2278. PubMed ID: 28520526
[TBL] [Abstract][Full Text] [Related]
12. Class II-associated invariant chain peptide down-modulation enhances the immunogenicity of myeloid leukemic blasts resulting in increased CD4+ T-cell responses.
van Luijn MM; Chamuleau ME; Thompson JA; Ostrand-Rosenberg S; Westers TM; Souwer Y; Ossenkoppele GJ; van Ham SM; van de Loosdrecht AA
Haematologica; 2010 Mar; 95(3):485-93. PubMed ID: 19903675
[TBL] [Abstract][Full Text] [Related]
13. PD-1/PD-L1 interactions contribute to functional T-cell impairment in patients who relapse with cancer after allogeneic stem cell transplantation.
Norde WJ; Maas F; Hobo W; Korman A; Quigley M; Kester MG; Hebeda K; Falkenburg JH; Schaap N; de Witte TM; van der Voort R; Dolstra H
Cancer Res; 2011 Aug; 71(15):5111-22. PubMed ID: 21659460
[TBL] [Abstract][Full Text] [Related]
14. Recurrent genetic HLA loss in AML relapsed after matched unrelated allogeneic hematopoietic cell transplantation.
Jan M; Leventhal MJ; Morgan EA; Wengrod JC; Nag A; Drinan SD; Wollison BM; Ducar MD; Thorner AR; Leppanen S; Baronas J; Stevens J; Lane WJ; Kekre N; Ho VT; Koreth J; Cutler CS; Nikiforow S; Alyea EP; Antin JH; Soiffer RJ; Ritz J; Lindsley RC; Ebert BL
Blood Adv; 2019 Jul; 3(14):2199-2204. PubMed ID: 31324640
[TBL] [Abstract][Full Text] [Related]
15. The dynamics of RUNX1-RUNX1T1 transcript levels after allogeneic hematopoietic stem cell transplantation predict relapse in patients with t(8;21) acute myeloid leukemia.
Qin YZ; Wang Y; Xu LP; Zhang XH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Chen Y; Mo XD; Zhao XS; Chang YJ; Liu KY; Huang XJ
J Hematol Oncol; 2017 Feb; 10(1):44. PubMed ID: 28166825
[TBL] [Abstract][Full Text] [Related]
16. Deregulated Expression of Circular RNAs Is Associated with Immune Evasion and Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.
Zhao F; Zhang X; Pei X; Yang D; Han M
Genes (Basel); 2022 Oct; 13(11):. PubMed ID: 36360223
[TBL] [Abstract][Full Text] [Related]
17. Treosulfan, fludarabine, and 2-Gy total body irradiation followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and acute myeloid leukemia.
Gyurkocza B; Gutman J; Nemecek ER; Bar M; Milano F; Ramakrishnan A; Scott B; Fang M; Wood B; Pagel JM; Baumgart J; Delaney C; Maziarz RT; Sandmaier BM; Estey EH; Appelbaum FR; Storer BE; Deeg HJ
Biol Blood Marrow Transplant; 2014 Apr; 20(4):549-55. PubMed ID: 24440648
[TBL] [Abstract][Full Text] [Related]
18. Loss of mismatched HLA in leukemia after stem-cell transplantation.
Vago L; Perna SK; Zanussi M; Mazzi B; Barlassina C; Stanghellini MT; Perrelli NF; Cosentino C; Torri F; Angius A; Forno B; Casucci M; Bernardi M; Peccatori J; Corti C; Bondanza A; Ferrari M; Rossini S; Roncarolo MG; Bordignon C; Bonini C; Ciceri F; Fleischhauer K
N Engl J Med; 2009 Jul; 361(5):478-88. PubMed ID: 19641204
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the CtBP complex and FBXO11 enhances MHC class II expression and anti-cancer immune responses.
Chan KL; Gomez J; Cardinez C; Kumari N; Sparbier CE; Lam EYN; Yeung MM; Garciaz S; Kuzich JA; Ong DM; Brown FC; Chan YC; Vassiliadis D; Wainwright EN; Motazedian A; Gillespie A; Fennell KA; Lai J; House IG; Macpherson L; Ang CS; Dawson SJ; Beavis PA; Wei AH; Burr ML; Dawson MA
Cancer Cell; 2022 Oct; 40(10):1190-1206.e9. PubMed ID: 36179686
[TBL] [Abstract][Full Text] [Related]
20. The Role of Immune Checkpoint Molecules for Relapse After Allogeneic Hematopoietic Cell Transplantation.
Köhler N; Ruess DA; Kesselring R; Zeiser R
Front Immunol; 2021; 12():634435. PubMed ID: 33746972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
